Dr Reddy’s buys Novartis cardiovascular brand Cidmus in India for Rs 456 crore

Dr. Reddy’s will look to leverage its wide base to engage with healthcare professionals, and to significantly enhance the reach of the product in and beyond metros into tier-I and tier-II markets in India through its strong marketing and distribution network to maximise access to patients in need.